[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100627897":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":13,"centralContacts":18,"locations":28,"responsibleParty":44,"collaborators":7,"id":46,"slug":7,"hasResults":47,"nctId":48,"briefTitle":49,"officialTitle":49,"acronym":50,"eligibilityCriteria":51,"healthyVolunteers":47,"sex":52,"minAge":53,"maxAge":54,"enrollmentInfo":55,"targetDuration":7,"studyType":58,"phases":7,"briefSummary":59,"conditions":60,"keywords":64,"overallStatus":68,"whyStopped":7,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":78},{"fullName":5,"class":6},"Wren Laboratories LLC","INDUSTRY",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"DIAGNOSTIC_TEST","PROSTEST","BLOOD SAMPLE FOR PROSTEST MEASUREMENT",[14],{"name":15,"affiliation":16,"role":17},"Abdel Halim, PharmD, PhD","Wren Laboratories","STUDY_CHAIR",[19,24],{"name":20,"role":21,"phone":22,"phoneExt":7,"email":23},"Mark Kidd, PhD","CONTACT","2038241128","mkidd@wrenlaboratories.com",{"name":25,"role":21,"phone":26,"phoneExt":7,"email":27},"Tracy Auster, BS","2032083464","tauster@wrenlaboratories.com",[29],{"facility":16,"status":7,"city":30,"state":31,"zip":32,"country":33,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"Branford","Connecticut","06405","United States","US",{"type":36,"coordinates":37},"Point",[38,39],-72.8151,41.27954,{"lat":39,"lon":38},[42,43],{"name":20,"role":21,"phone":22,"phoneExt":7,"email":23},{"name":25,"role":21,"phone":26,"phoneExt":7,"email":27},{"type":45,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100627897",false,"NCT07454603","A Prospective Clinical Trial Evaluating PROSTest, a Blood-Based Molecular Assay, for Risk Stratification and Biopsy Decision Support in Men With Suspected Prostate Cancer","PROSTest_STRAT","Inclusion Criteria:\n\n* elevated PSA and\u002For abnormal digital rectal examination\n\nExclusion Criteria:\n\n* Previous Prostate cancer diagnosis","MALE","45 Years","80 Years",{"count":56,"type":57},1500,"ESTIMATED","OBSERVATIONAL","This prospective observational study will enroll men referred for prostate biopsy due to elevated PSA and\u002For abnormal digital rectal examination, with or without pre-biopsy MRI. Peripheral blood will be collected prior to biopsy for PROSTest analysis. Biopsy histopathology will serve as the reference standard. PROSTest results will be analyzed blinded to pathology.",[61,62,63],"Prostate Cancer","Urology","Prostate Cancer (Diagnosis)",[65,66,67],"BIOPSY","MRI","PROSTATE CANCER","NOT_YET_RECRUITING","2026-03-02",{"date":71,"type":72},"2026-03-06","ACTUAL",{"date":74,"type":57},"2026-03-15",{"date":76,"type":57},"2027-06-01",{"name":5,"class":6},1]